Everest Biolabs
Everest Biolabs is a Waltham-based company in biotechnology tools, listed in Section 1 of the Raise Track Update of 2026-09-25.
- Industry
- biotechnology tools
- Location
- Waltham, MA
About
Everest Biolabs is listed in Section 1 of the Raise Track Update of 2026-09-25, which gives the round as $2.4M (Pre-Seed). Investors named in the issue: not disclosed in the issue. The issue describes the company this way: Everest Biolabs, a Waltham, MA-based provider of automated extracellular vesicle (EV) isolation and analytics solutions, received $2.1M Small Business Innovation Research (SBIR) Direct-to-Phase II grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH) The company intends to use the funds to expand operations and its R&D efforts.
The issue lists $2.4M (Pre-Seed), but its headline and description describe a $2.1M SBIR Direct-to-Phase II grant from the National Institute of General Medical Sciences, so no amount is shown until a second source settles it.
This page is not indexed by search engines yet. It is promoted once a second source, separate from the newsletter, confirms the round.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Pre-Seed 2026 | 2026-09-25 |
Sources
Last verified:
- https://www.finsmes.com/2026/09/everest-biolabs-receives-2-1m-grant.html
Type: reputable publication. Accessed 2026-10-12.
Article linked from the Raise Track Update for 2026-09-25. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-09-25/
Type: other verified public source. Accessed 2026-10-12.
Raise Track Update for 2026-09-25, Section 1. Lists Everest Biolabs at $2.4M (Pre-Seed) with investors: undisclosed.